# Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation

> **NCT05179902** · — · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 190 (estimated)

## Conditions studied

- Women and Men Over 18 Years Old
- AF Ablation (ECS recommendation2020&ACS2014) Either for Paroxysmal AF Unresponsive to Anti-arrhythmic Treatment Either for Persisting Symptomatic AF
- Able to Give His Non Opposition to Participate to the Study

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05179902
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-20
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2022-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05179902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05179902, "Predictive Properties of Myocardial Fibrosis Biomarkers on the Outcome of Atrial Fibrillation Ablation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05179902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*